Clinical Trials Directory

Trials / Completed

CompletedNCT01150474

Postoperative Belladonna and Morphine Suppositories in Vaginal Surgery

Randomized Clinical Trial of Postoperative Belladonna and Morphine Suppositories in Vaginal Surgery

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
103 (actual)
Sponsor
Kristina A. Butler · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

Our primary aim is to determine whether the routine use of belladonna and morphine suppositories will improve pain control following vaginal surgery. Treatment will begin immediately following surgery and every 8 hours for 16 hours.

Detailed description

Minimizing postoperative pain is vital to a successful surgical recovery. Inadequate pain control may result in nausea, vomiting, an extended hospital stay, and reduced patient satisfaction. Oral and parenteral narcotics are commonly used for pain relief and their use may exacerbate the incidence of sedation, nausea, and vomiting; ultimately delaying convalescence. Previous studies have demonstrated that rectal analgesia following surgery results in lower pain scores and less intravenous morphine consumption. Belladonna and opium suppositories are routinely prescribed at our institution and their efficacy has not been confirmed. A prospective, randomized, double-blind, placebo-controlled trial will be undertaken using belladonna and opium rectal suppositories following vaginal surgery. Treatment will begin immediately following surgery and continue every 8 hours for a total of 3 doses.

Conditions

Interventions

TypeNameDescription
DRUGBelladonna and Opium SuppositoriesBelladonna (16.2 mg) and opium (60 mg) suppositories administered rectally immediately following surgery and every 8 hours for 16 hours for a total of 3 doses.
DRUGPlacebo SuppositoriesPlacebo suppositories administered rectally immediately following surgery and every 8 hours for 16 hours for a total of 3 doses.

Timeline

Start date
2011-01-01
Primary completion
2013-12-01
Completion
2013-12-01
First posted
2010-06-25
Last updated
2015-01-07
Results posted
2015-01-07

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01150474. Inclusion in this directory is not an endorsement.